u/cvchbvjbvghbvhbvgg

Tried to place a buy order this week and got blocked: PRIIPs rules mean QQQI (and most NEOS/YieldMax products) aren’t available to UK retail. No KID = no trade. The screenshot I got literally said “Client has a legal residence in the UK and is not eligible to purchase US registered ETFs, ETNs or closed-end funds.”
So I’m trying to build a similar Nasdaq-100 income sleeve inside a Stocks & Shares ISA (tax-free dividends, £20k/year cap). The UCITS options I’ve found so far:
• JEPQ.L (JPMorgan Nasdaq Equity Premium Income, 0.35% TER, ~10.6% yield) — closest match to QQQI’s partial-overlay style, keeps more upside
• QQIA.L (Invesco Nasdaq-100 Income Advantage, 0.29% TER) — covered calls + cash-secured puts, but only launched Feb 2026 so barely any track record
• QYLD.L / QYLP.L (Global X, 0.45% TER, ~12% yield) — highest headline yield, but full buy-write so price keeps eroding
Questions for anyone in the same boat:
1. Anyone running JEPQ.L for a while — how’s the total return holding up vs the headline yield?
2. Has anyone touched QQIA.L yet or is it too new?
3. Anyone gone the route of opting up to elective professional client status with IBKR to access QQQI directly? Worth the loss of retail protections?
4. Any UK-accessible names I’m missing — particularly anything with the SPYI/QQQI tax-efficient ROC structure rather than straight dividend distributions?
Cheers.